Clearstead Trust, LLC Vertex Pharmaceuticals Inc Transaction History
Clearstead Trust, LLC
- $414 Million
- Q4 2024
A detailed history of Clearstead Trust, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Clearstead Trust, LLC holds 234 shares of VRTX stock, worth $110,391. This represents 0.02% of its overall portfolio holdings.
Number of Shares
234
Previous 137
70.8%
Holding current value
$110,391
Previous $63,000
49.21%
% of portfolio
0.02%
Previous 0.02%
Shares
12 transactions
Others Institutions Holding VRTX
# of Institutions
1,752Shares Held
227MCall Options Held
1.63MPut Options Held
1.47M-
Capital World Investors Los Angeles, CA28.3MShares$13.4 Billion1.8% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.3MShares$11 Billion0.17% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$10.1 Billion0.23% of portfolio
-
State Street Corp Boston, MA12MShares$5.65 Billion0.2% of portfolio
-
Capital Research Global Investors Los Angeles, CA10.4MShares$4.92 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $121B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...